Filana Therapeutics, Inc.(FLNA)

Biotechnology · Austin, TX

$0.87+0.01 (+0.59%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T22:16:55.211Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:16:55.211Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.8749
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.87

FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

FLNA PE Ratio Metrics

PE RATIO

N/A

FLNA Competitors' PE Ratio

FLNA

Filana Therapeutics, Inc.

Current

Market Cap

$42.26M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BSEM

BioStem Technologies, Inc.

vs FLNA

Market Cap

$41.95M

PE Ratio

N/A

TTM Avg

7.83

3Y Avg

14.59

5Y Avg

14.59

PRPO

Precipio, Inc.

vs FLNA

Market Cap

$41.83M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RPID

Rapid Micro Biosystems, Inc.

vs FLNA

Market Cap

$42.72M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NNOX

Nano-X Imaging Ltd.

vs FLNA

Market Cap

$42.83M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CVRX

CVRx, Inc.

vs FLNA

Market Cap

$42.99M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DRIO

DarioHealth Corp.

vs FLNA

Market Cap

$44.02M

PE Ratio

8.72

TTM Avg

6.98

3Y Avg

6.98

5Y Avg

6.98

SNWV

SANUWAVE Health Inc.

vs FLNA

Market Cap

$44.71M

PE Ratio

5.75

TTM Avg

15.10

3Y Avg

15.10

5Y Avg

15.10

HOWL

Werewolf Therapeutics, Inc.

vs FLNA

Market Cap

$44.72M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VERU

Veru Inc.

vs FLNA

Market Cap

$39.64M

PE Ratio

N/A

TTM Avg

243.89

3Y Avg

230.07

5Y Avg

202.94

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Filana Therapeutics, Inc. (FLNA)	$42.26M	N/A	N/A	N/A	N/A
BioStem Technologies, Inc. (BSEM)vs ›	$41.95M	N/A	7.83	14.59	14.59
Precipio, Inc. (PRPO)vs ›	$41.83M	N/A	N/A	N/A	N/A
Rapid Micro Biosystems, Inc. (RPID)vs ›	$42.72M	N/A	N/A	N/A	N/A
Nano-X Imaging Ltd. (NNOX)vs ›	$42.83M	N/A	N/A	N/A	N/A
CVRx, Inc. (CVRX)vs ›	$42.99M	N/A	N/A	N/A	N/A
DarioHealth Corp. (DRIO)vs ›	$44.02M	8.72	6.98	6.98	6.98
SANUWAVE Health Inc. (SNWV)vs ›	$44.71M	5.75	15.10	15.10	15.10
Werewolf Therapeutics, Inc. (HOWL)vs ›	$44.72M	N/A	N/A	N/A	N/A
Veru Inc. (VERU)vs ›	$39.64M	N/A	243.89	230.07	202.94

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.87

Forward EPS (Est.)

$-0.89

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

FLNA PE Ratio Metrics

FLNA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics